Ribociclib
Novartis
['breast']
new results on the use of kisquali, a breast cancer pill, were presented at #asco23. 's talks with about the findings: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090